Technology Transfer Program Commercial Assessment Leads

The Food and Drug Administration is seeking support to enhance its Technology Transfer Program by engaging a contractor to provide comprehensive marketing data that evaluates the commercial potential of FDA inventions. This effort aims to assist program staff in making informed decisions regarding the marketability of technologies developed within the agency, facilitating more effective transfer to private sector partners. The contractor will be responsible for delivering actionable insights into market trends, competitive landscapes, regulatory pathways, and commercialization readiness for FDA-owned innovations. The contract falls under the NAICS code 541199 for other professional, scientific, and technical services and is currently displayed as a forecast with no solicitation number yet issued. All work is expected to support FDA internally, with no specific place of performance designated. The primary point of contact for program-related inquiries is the Oc Acquisition Liaison at ocacquisitions@fda.hhs.gov, while the contracting officer position remains to be determined. Interested parties should monitor the FDA’s opportunity forecast page for future solicitation details, as this is a pre-solicitation notice indicating the agency’s intent to procure services in the near future.